CODX - Co-Diagnostics, Inc. Price to Earnings Adjusted for Growth Rate

Co-Diagnostics, Inc. (CODX) develops PCR systems for human and livestock health monitoring, ensuring environmental safety. Expanding its geographic footprint across Europe and the US, combined with a diversified test portfolio, minimizes operational risks. A stable image as a reliable supplier is sustained by the trust of laboratories. The average PEG ratio demonstrates the business valuation dynamics, where 0.00 becomes the new value for this metric.

US export control risks and trade tensions with China directly impact the sales of Co-Diagnostics, Inc. (CODX) systems. The PEG ratio compares the current earnings multiple to the rate of business expansion, determining the cost per unit of future growth. A value below one signals that the asset is undervalued relative to its dynamics. The investor assesses the extent to which the market is discounting the issuer's operational threats. By analyzing this ratio of value to business expansion rates, one can determine the entry point into a "growth" asset.